Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01833364 · ClinicalTrials.gov registry record · NA
Autologous Peripheral Nerve Grafts Into the Substantia Nigra of Subjects With PD Undergoing Deep Brain Stimulation
A NA study, sponsored by Craig van Horne, MD, PhD.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01833364 is a NA study that has completed, run by Craig van Horne, MD, PhD. The registered enrollment target is 8 participants.
The verdict
NCT01833364, a NA study, has completed, sponsored by Craig van Horne, MD, PhD.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
By doing this study, the investigators hope to learn provide safety data that can be used to generate a larger phase III clinical trial. If successful, it would promote the development of a new treatment for PD in which patients are able to provide their own tissue as a source of a supportive environment for the injured and dying cells and thereby possibly stopping the progression of the illness or even improve the symptoms of PD. The purpose of this research is to gather information on the safety and feasibility of nerve graft implantation is. The results of this study will be shared with the University of Kentucky, Center for Clinical and Translational Science (group providing financial support for the study) and other federal agencies, if required. The overall goal of this research is to develop a novel, regenerative treatment strategy for idiopathic Parkinson's disease (PD) that is safe, cost effective and widely available to patients.
Interventions
- PROCEDURE Implantation of the Peripheral Nerve Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-04 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01833364
The ClinicalTrials.gov registry entry for NCT01833364 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Craig van Horne, MD, PhD, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Implantation of the Peripheral Nerve Graft is the first listed.
NCT01833364 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01833364 about?
NCT01833364 is a clinical study titled "Autologous Peripheral Nerve Grafts Into the Substantia Nigra of Subjects With PD Undergoing Deep Brain Stimulation". By doing this study, the investigators hope to learn provide safety data that can be used to generate a larger phase III clinical trial. If successful, it would promote the development of a new treatment for PD in which patients are able to provide their own tissue as a source of a supportive enviro...
What is the current status of trial NCT01833364?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2013-04. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01833364?
The interventions under investigation include: Implantation of the Peripheral Nerve Graft (PROCEDURE).
Who is sponsoring clinical trial NCT01833364?
This trial is sponsored by Craig van Horne, MD, PhD, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.